Market Overview

Perrigo Buys Remaining Stake in Cobrek Pharma for ~$45M

Share:
Related PRGO
Benzinga's M&A Chatter for Wednesday July 29, 2015
RBC Says Stay Away From Mylan, Perrigo; Go Long Teva, Allergan
Shire Offers $30 Billion For Ex-Baxter Unit Baxalta (Investor's Business Daily)

Perrigo Company (Nasdaq: PRGO) today announced that it has signed a definitive merger agreement and has completed the acquisition of Cobrek Pharmaceuticals, Inc. (Cobrek), a privately-held, Chicago, Illinois-based drug development company, for approximately $45 million on a cash free and debt free basis.

Posted-In: News M&A

 

Related Articles (PRGO)

Get Benzinga's Newsletters